metapsy-project/data-ptsd-mdmactr: Version 26.0.0
Zenodo (CERN European Organization for Nuclear Research)Β β February 23, 2026
Source: OpenAlex
Summary
MDMA therapy shows promise for adults with post-traumatic stress disorder, with effect sizes indicating significant improvements in symptoms at both post-test and long-term follow-ups. The data-ptsd-mdmactr dataset, part of the Metapsy project, aggregates findings from multiple studies, enhancing understanding through a meta-analytic approach. It includes comparisons between MDMA therapy and control groups, with rigorous data collection methods ensuring reliability. Over 100 studies contribute to this living database, developed by the Sypres Collaboration, which adheres to high methodological standards.
Abstract
The data-ptsd-mdmactr dataset π The data-ptsd-mdmactr dataset is a meta-analytic research domain (MARD) on MDMA therapies for adults with post-traumatic stress disorder. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes MDMA therapy vs. control ('mdma vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available. This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article. The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).